###begin article-title 0
Proteasomal Degradation of TRIM5alpha during Retrovirus Restriction
###end article-title 0
###begin p 1
Conceived and designed the experiments: CR CA. Performed the experiments: CR. Analyzed the data: CR CA. Wrote the paper: CR CA.
###end p 1
###begin p 2
###xml 488 493 <span type="species:ncbi:9606">human</span>
###xml 532 537 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 591 596 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 609 623 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 745 755 <span type="species:ncbi:9505">owl monkey</span>
###xml 875 880 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 985 990 <span type="species:ncbi:9606">human</span>
###xml 1076 1097 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 1201 1206 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1228 1242 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1333 1347 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1364 1369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The host protein TRIM5alpha inhibits retroviral infection at an early post-penetration stage by targeting the incoming viral capsid. While the detailed mechanism of restriction remains unclear, recent studies have implicated the activity of cellular proteasomes in the restriction of retroviral reverse transcription imposed by TRIM5alpha. Here, we show that TRIM5alpha is rapidly degraded upon encounter of a restriction-susceptible retroviral core. Inoculation of TRIM5alpha-expressing human 293T cells with a saturating level of HIV-1 particles resulted in accelerated degradation of the HIV-1-restrictive rhesus macaque TRIM5alpha protein but not the nonrestrictive human TRIM5alpha protein. Exposure of cells to HIV-1 also destabilized the owl monkey restriction factor TRIMCyp; this was prevented by addition of the inhibitor cyclosporin A and was not observed with an HIV-1 virus containing a mutation in the capsid protein that relieves restriction by TRIMCyp IVHIV. Likewise, human TRIM5alpha was rapidly degraded upon encounter of the restriction-sensitive N-tropic murine leukemia virus (N-MLV) but not the unrestricted B-MLV. Pretreatment of cells with proteasome inhibitors prevented the HIV-1-induced loss of both rhesus macaque TRIM5alpha and TRIMCyp proteins. We also detected degradation of endogenous TRIM5alpha in rhesus macaque cells following HIV-1 infection. We conclude that engagement of a restriction-sensitive retrovirus core results in TRIM5alpha degradation by a proteasome-dependent mechanism.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 235 241 <span type="species:ncbi:9606">humans</span>
###xml 245 248 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recent studies have identified several cellular proteins that restrict infection by a variety of retroviruses. One of these restriction factors, TRIM5alpha, is partially responsible for the differences in susceptibility of monkeys and humans to SIV and HIV-1, respectively. TRIM5alpha inhibits retrovirus infection soon after penetration into the target cell by associating with the viral protein CA, which forms the polymeric capsid shell of the viral core. Although the detailed mechanism of restriction is unknown, TRIM5alpha is postulated to alter the stability of the viral core, resulting in a failure to complete reverse transcription. The activity of cellular proteasomes, which are responsible for intracellular protein degradation, has also been implicated in TRIM5alpha-dependent attenuation of retroviral reverse transcription. In this study, we show that cellular TRIM5alpha is rapidly degraded in cells exposed to a restriction-sensitive retrovirus but not in cells infected with an unrestricted virus. Virus-induced degradation of TRIM5alpha was dependent on cellular proteasome activity, as inhibition with drugs blocking proteasome function also inhibited degradation of TRIM5alpha. These results provide additional support for a role of proteasomal degradation in TRIM5alpha-dependent retrovirus restriction and suggest a novel mechanism by which binding of TRIM5alpha to the viral capsid prevents infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Best1">[1]</xref>
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Nisole1">[5]</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Bieniasz1">[6]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Sokolskaja1">[10]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Pincus1">[11]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Lilly1">[13]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Pryciak1">[14]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Jolicoeur1">[15]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Pincus1">[11]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Boone1">[16]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Kozak1">[17]</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Boone2">[19]</xref>
###xml 932 935 932 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Best1">[1]</xref>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 485 508 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 510 513 <span type="species:ncbi:11786">MLV</span>
###xml 987 990 <span type="species:ncbi:11786">MLV</span>
Retroviruses exhibit a restricted host range due to the requirement for specific interactions between viral and host proteins to complete the viral life cycle. Also limiting retroviral tropism are several recently identified intracellular antiviral factors ([1]-[5]); reviewed in [6]-[10]). The prototypical restriction activity, Fv1, was first detected in the 1970s as differential susceptibility of inbred mice strains to the Friend leukemia virus [11]-[13]. Fv1 blocks infection of murine leukemia viruses (MLV) at a stage following fusion but prior to integration [14],[15]. The block to infection can be overcome at high multiplicities of infection (m.o.i.) or by pretreatment of target cells with non-infectious virus like particles (VLPs) [11],[16]. Susceptibility to Fv1 restriction is determined by the sequence of the viral capsid protein (CA) [17]-[19]. The gene encoding Fv1 was identified in 1996 by positional cloning [1]; yet the molecular mechanism by which Fv1 inhibits MLV infection remains poorly defined.
###end p 6
###begin p 7
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Munk1">[20]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Schmitz1">[25]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Cowan1">[23]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Schmitz1">[25]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Kootstra1">[27]</xref>
###xml 404 407 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 409 413 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Ylinen1">[28]</xref>
###xml 414 418 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Song1">[31]</xref>
###xml 483 485 471 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 556 559 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 645 648 629 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 649 653 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Munk1">[20]</xref>
###xml 654 658 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Cowan1">[23]</xref>
###xml 659 663 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Besnier1">[24]</xref>
###xml 722 724 698 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 914 918 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Hatziioannou2">[29]</xref>
###xml 920 924 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Keckesova1">[30]</xref>
###xml 926 930 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Yap1">[32]</xref>
###xml 931 935 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Zhang1">[37]</xref>
###xml 1071 1075 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Ylinen1">[28]</xref>
###xml 1076 1080 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Song1">[31]</xref>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 200 203 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 208 211 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 372 377 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 438 452 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 550 555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 669 674 <span type="species:ncbi:9606">human</span>
###xml 782 785 <span type="species:ncbi:11786">MLV</span>
###xml 789 792 <span type="species:ncbi:11786">MLV</span>
###xml 795 824 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 826 829 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 836 866 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 868 872 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 908 913 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1049 1054 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1056 1061 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1067 1070 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Recent investigations have identified additional restriction activities present in human and simian cells that govern the tropism of lentiviruses, including human and simian immunodeficiency viruses (HIV and SIV) [20]-[25]. Like Fv1, these restrictions target the incoming viral capsid [23], [25]-[27]. One factor, TRIM5alpha, is responsible for post-entry restriction of HIV-1 in many simian cell lines [3], [28]-[31]. Expression of the rhesus macaque TRIM5alpha protein (TRIM5alpharh) in human cells renders them highly restrictive to infection by HIV-1 [3]. Unlike Fv1, TRIM5alpha acts at a stage prior to completion of reverse transcription [3],[20],[23],[24]. The human genome encodes a TRIM5alpha protein (TRIM5alphahu) that restricts multiple retroviruses including N-tropic MLV (N-MLV), feline immunodeficiency virus (FIV), and equine infectious anemia virus (EIAV) but does not efficiently restrict HIV-1 [29], [30], [32]-[37]. TRIM5alpha cDNAs have now been cloned from multiple primate species; these differentially restrict infection by HIV-1, HIV-2, and SIV [28],[31].
###end p 7
###begin p 8
###xml 112 115 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Sayah1">[4]</xref>
###xml 116 119 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Nisole1">[5]</xref>
###xml 326 329 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Sayah1">[4]</xref>
###xml 642 646 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Towers1">[38]</xref>
###xml 769 772 765 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Sayah1">[4]</xref>
###xml 773 776 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Nisole1">[5]</xref>
###xml 870 874 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Brennan1">[39]</xref>
###xml 875 879 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Wilson1">[42]</xref>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 100 111 <span type="species:ncbi:9505">owl monkeys</span>
###xml 357 362 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 595 605 <span type="species:ncbi:9505">owl monkey</span>
###xml 626 631 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Shortly after the identification of TRIM5alpha, a second HIV-1 restriction factor was identified in owl monkeys [4],[5]. This protein, TRIMCyp, is the apparent result of a LINE1-mediated retrotransposition event in which the cyclophilin A (CypA) mRNA was inserted into the TRIM5 locus resulting in a functional fusion protein [4]. TRIMCyp potently inhibits HIV-1 infection by interacting with an exposed loop on the surface of the CA via the CypA domain. The discovery of TRIMCyp provided a simple explanation for the ability of cyclosporin A (CsA), which inhibits CypA binding to CA, to render owl monkey cells permissive to HIV-1 infection [38]. Mutations in the CypA binding loop that result in a failure to bind CypA also result in a loss of restriction by TRIMCyp [4],[5]. More recently, novel TRIM5-CypA proteins have also been identified in other primate species [39]-[42].
###end p 8
###begin p 9
###xml 136 140 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Reymond1">[43]</xref>
###xml 499 503 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Hatziioannou2">[29]</xref>
###xml 505 509 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Keckesova1">[30]</xref>
###xml 511 515 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Yap2">[33]</xref>
###xml 517 521 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau2">[34]</xref>
###xml 523 527 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Perron1">[36]</xref>
###xml 529 533 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero1">[44]</xref>
###xml 534 538 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Nakayama1">[46]</xref>
###xml 659 663 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero1">[44]</xref>
###xml 664 668 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Mische1">[47]</xref>
###xml 669 673 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Javanbakht1">[48]</xref>
###xml 836 840 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero1">[44]</xref>
###xml 841 845 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Javanbakht2">[49]</xref>
###xml 1074 1077 1042 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 1078 1082 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero1">[44]</xref>
###xml 1083 1087 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Javanbakht2">[49]</xref>
###xml 1306 1310 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Zhang1">[37]</xref>
###xml 1312 1316 1280 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Yap3">[50]</xref>
###xml 1317 1321 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Li2">[52]</xref>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
TRIM5alpha and TRIMCyp are members of the tripartite motif family of proteins, which encode RING, B-Box, and coiled-coil (RBCC) domains [43]. TRIM5alpha is the longest of the three isoforms (alpha, gamma, and delta) generated from the TRIM5 locus by alternative splicing of the primary transcript. While all three TRIM5 isoforms contain identical RBCC domains, the alpha-transcript also encodes the B30.2/SPRY domain required for recognition of the incoming viral capsid and restriction specificity [29], [30], [33], [34], [36], [44]-[46]. The coiled-coil domain promotes the multimerization of TRIM5alpha molecules that is required for efficient restriction [44],[47],[48]. While the precise function of the B-Box domain is unclear, deletion of this region results in total loss of restriction potential thus indicating its importance [44],[49]. The RING domain of TRIM5alpha is also required for full restriction activity, as mutants that lack this domain or in which proper folding is impaired are severely impaired for restriction and have altered cellular localization [3],[44],[49]. Substitution of RING domains from other human TRIM proteins results in changes in both the timing of restriction (i.e. pre- vs. post-reverse transcription) and the intracellular localization of the restriction factor [37], [50]-[52].
###end p 9
###begin p 10
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Meroni1">[53]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Jackson1">[54]</xref>
###xml 345 349 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero1">[55]</xref>
###xml 552 560 536 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 617 621 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Xu1">[56]</xref>
###xml 1011 1015 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero2">[57]</xref>
###xml 1196 1200 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Wu1">[58]</xref>
###xml 1201 1205 1173 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Anderson1">[59]</xref>
###xml 1168 1173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
RING domains are commonly associated with ubiquitin ligase (E3) activity facilitating specific transfer of ubiquitin from various ubiquitin-conjugating (E2) proteins to substrates (reviewed in [53],[54]). Polyubiquitylation of proteins commonly targets them for intracellular degradation by proteasomes. TRIM5alpha can be ubiquitylated in cells [55], but a role for this modification in TRIM5alpha stability or restriction has not been established. The delta isoform of TRIM5, which encodes an identical RING domain to TRIM5alpha, exhibits E3 activity in vitro and mutation of the RING domain abolishes this activity [56]. The presence of a RING domain on TRIM5alpha suggested that the restriction factor might function by transferring ubiquitin to a core-associated viral protein, thus targeting it for proteasomal degradation. However, such a modification has not been detected, and the magnitude of restriction imposed by TRIM5alpha was not altered in cells in which the ubiquitination pathway was disrupted [57]. Nonetheless, recent studies have shown that proteasome inhibitors relieve the TRIM5alpha-dependent inhibition of reverse transcription, yet a block to HIV-1 nuclear entry remains [58],[59].
###end p 10
###begin p 11
###xml 574 576 546 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 535 540 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Based on these findings implicating the proteasome in TRIM5alpha-dependent retroviral restriction, we hypothesized that restriction by TRIM5alpha leads to proteasomal degradation of a TRIM5alpha-viral protein complex. Here we show that inoculation of TRIM5alpha-expressing cells with a restricted retrovirus results in accelerated degradation of TRIM5alpha itself. Destabilization of TRIM5alpha was tightly correlated with the ability of the restriction factor to block infection by the incoming virus. Proteasome inhibitors prevented HIV-1-induced degradation of TRIM5alpharh when added to cells prior to virus inoculation. These data suggest a functional link between proteasomal degradation of TRIM5alpha and the ability of TRIM5alpha to restrict an incoming retrovirus.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Exposure of Cells to HIV-1 Destabilizes TRIM5alpha
###end title 13
###begin p 14
###xml 137 139 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 570 579 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1A</xref>
###xml 867 876 843 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1B</xref>
###xml 1006 1010 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero1">[55]</xref>
###xml 1108 1110 1076 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 280 285 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 612 617 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 816 821 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1080 1085 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We hypothesized that TRIM5alpha itself might be degraded as a consequence of the post-entry restriction process. To test this, TRIM5alpharh-expressing 293T cells were cultured in the presence of cycloheximide to arrest protein synthesis and then challenged with VSV-G-pseudotyped HIV-1 particles. At various times post-infection, cells were harvested for analysis of TRIM5alpha levels by quantitative immunoblotting. In control cells not exposed to virus, the TRIM5alpha level declined at a slow rate, eventually leveling off to 55% of the original level after 4 hours (Figure 1A). By contrast, inoculation with HIV-1 induced a more rapid decrease in the TRIM5alpha level resulting in 85% loss after 4 hours. Analysis of data from 4 experiments indicated that the decay of TRIM5alpha was significantly faster in the HIV-1-inoculated cultures relative to the control (Figure 1B). The stability of TRIM5alpha in our cells differs in terms of time as compared to previously published reports using Hela cells [55]. In additional studies we observed a similar destabilizing effect of HIV-1 exposure on TRIM5alpharh in HeLa cells (data not shown).
###end p 14
###begin title 15
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Destabilization of TRIM5alpha upon challenge of cells with HIV-1.
###end title 15
###begin p 16
###xml 112 114 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 716 718 678 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 227 232 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 667 672 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 870 873 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Immunoblot analysis of TRIM5alpha in cells challenged with HIV-1. 293T cells expressing HA-tagged TRIM5alpharh were pretreated for 1 hour with cycloheximide at 37degreesC. Cells were then challenged with stock solutions of HIV-1(VSV) or media alone (Mock). (B) Quantitation of TRIM5alpha levels utilizing Odyssey Band imaging software. The TRIM5alpha levels are expressed as a percentage of the ratio of TRIM5alpha:actin signal to the zero hour sample TRIM5alpha:actin signal. Shown are the mean values and standard deviations obtained in four independent experiments. h.p.i. = Hours post infection. (C) Immunoblot analysis of TRIM5alpha in cells challenged with HIV-1. 293T cells expressing HA-tagged TRIM5alpharh were pretreated for 1 hour with cycloheximide at 37degreesC. Cells were then challenged with media alone (Mock) or the indicated amount of pseudotyped HIV-GFP expressed as quantity of p24 (CA) for a period of three hours. (D) Relationship of TRIM5alpha level to permissivity of target cells. A portion of the cultures harvested in (C) were recultured for 48 hours and subsequently analyzed for GFP expression by flow cytometry. Shown are the mean values for the two replicates for both TRIM5alpha levels and extent of infection.
###end p 16
###begin p 17
###xml 147 149 139 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 216 218 204 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 713 715 689 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 766 775 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1C</xref>
###xml 892 901 864 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1D</xref>
###xml 932 937 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Exposure of target cells to saturating levels of virus or VLPs can overcome restriction by TRIM5alpha. To determine whether the decay of TRIM5alpharh was related to saturation of restriction, we inoculated TRIM5alpharh-expressing cells with various doses of a GFP-encoding virus in the presence of cycloheximide for a fixed period of time and harvested the cells to quantify TRIM5alpha levels. To probe the relationship between saturation of restriction and TRIM5alpha degradation, a portion of the harvested cells were replated and cultured for 48 hours, and the extent of infection determined by flow cytometric analysis of GFP expression. The results showed that the ability to detect degradation of TRIM5alpharh was strongly dependent on the dose of virus used (Figure 1C). Furthermore, the TRIM5alpha level following inoculation was inversely related to the overall extent of infection (Figure 1D). These results indicate that HIV-1-induced degradation of TRIM5alpha is correlated with saturation of restriction, likely due to a requirement to engage most of the restriction factor to detect the loss of the protein.
###end p 17
###begin title 18
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human TRIM5alpha Stability is Not Affected by HIV-1
###end title 18
###begin p 19
###xml 264 272 252 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1</xref>
###xml 303 305 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 398 413 382 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g002">Figure 2A and B</xref>
###xml 426 428 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 474 476 450 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 546 561 522 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g002">Figure 2B and C</xref>
###xml 651 653 623 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 714 716 682 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 829 831 793 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 234 239 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 274 279 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 590 595 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 675 680 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 872 877 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human TRIM5alpha does not efficiently restrict HIV-1 infection. To further probe the link between restriction and TRIM5alpha destabilization, we analyzed the stability of the human TRIM5alpha protein following challenge of cells with HIV-1. As previously shown in Figure 1, HIV-1 challenge of TRIM5alpharh-expressing 293T cells resulted in a more rapid loss of the protein vs. mock-infected cells (Figure 2A and B). TRIM5alphahu was intrinsically less stable than TRIM5alpharh, as indicated by its more rapid decay in the mock-infected cultures (Figure 2B and C). However, inoculation with HIV-1 did not result in further destabilization of TRIM5alphahu, indicating that the HIV-1-induced degradation of TRIM5alpharh is not a nonspecific cellular response to the viral challenge. These results suggest that the loss of TRIM5alpharh depends on its ability to recognize the HIV-1 core.
###end p 19
###begin title 20
###xml 0 14 <span type="species:ncbi:9544">Rhesus macaque</span>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Rhesus macaque, but not human TRIM5alpha, is less stable in cells challenged with HIV-1.
###end title 20
###begin p 21
###xml 46 48 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 62 64 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 172 180 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1</xref>
###xml 317 326 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s001">Figure S1</xref>
###xml 364 366 348 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 385 387 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 145 150 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) 293T cells expressing HA-tagged TRIM5alpharh or TRIM5alphahu were pretreated for 1 hour with cycloheximide then exposed to VSV-G pseudotyped HIV-1 or media alone as in Figure 1. TRIM5alpha was detected by immunoblotting with HA-specific antibody. Integrated intensity values for the individual bands are shown in Figure S1. (B and C) Quantitation of TRIM5alpharh (B) and TRIM5alphahu levels utilizing Odyssey imaging software. Data shown are from one representative of three independent experiments.
###end p 21
###begin title 22
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Exposure to Restriction-Sensitive HIV-1 Destabilizes TRIMCyp
###end title 22
###begin p 23
###xml 669 678 669 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g003">Figure 3A</xref>
###xml 831 840 831 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g003">Figure 3B</xref>
###xml 4 14 <span type="species:ncbi:9505">owl monkey</span>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 303 308 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 559 564 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 696 701 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 779 784 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The owl monkey restriction factor TRIMCyp restricts HIV-1 by binding to an exposed loop on the surface of CA. Restriction can be prevented by addition of CsA or amino acid substitutions in CA that reduce CypA binding. We therefore asked whether TRIMCyp would also be destabilized following encounter of HIV-1. 293T cells expressing TRIMCyp were treated with cycloheximide and then challenged with VSV-G pseudotyped HIV-1 particles. As a control, parallel cultures were inoculated in the presence of a CsA concentration known to abolish TRIMCyp restriction of HIV-1. In the control mock-inoculated cells, TRIMCyp was stable in the cells during the six-hour time course (Figure 3A). Challenge with HIV-1 resulted in accelerated loss of TRIMCyp. In the cultures containing CsA, the HIV-1-induced loss of TRIMCyp was markedly reduced (Figure 3B).
###end p 23
###begin title 24
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
TRIMCyp is destabilized in cells challenged with HIV-1.
###end title 24
###begin p 25
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1B</xref>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 484 486 480 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 790 799 782 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1B</xref>
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 172 177 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 187 192 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 615 618 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 647 650 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) 293T cells expressing the myc-His6 tagged TRIMCyp were pretreated for 1 hour with cycloheximide. Cells were then challenged with HIV-1(VSV) and either ethanol carrier (HIV-1) or CsA (HIV-1+CsA), or with media alone (Mock). All stocks contained cycloheximide. (B) Quantitation of TRIMCyp levels as described in the legend to Figure 1B. Data in this figure are from one of two independent experiments. (C) 293T cells expressing either myc-His6 tagged TRIMCyp or HA-tagged TRIM5alpharh were pretreated for 1 hour with cycloheximide. Cells were then challenged for 5 hours with stock solutions of VSV-G pseudotyped HIV-GFP (WT), VSV-G pseudotyped HIV-GFP with the G89V capsid mutation (G89V), or medium alone (M). (D) Quantitation of TRIMCyp and TRIM5alpha levels as described in legend to Figure 1B. Data in (D) are expressed as the mean values of four determinations from two experiments, with error bars representing one standard deviation.
###end p 25
###begin p 26
###xml 303 305 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 390 392 382 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 551 560 543 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g003">Figure 3C</xref>
###xml 645 647 633 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 730 732 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 114 119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 493 496 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 584 589 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 799 804 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 896 901 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next we asked whether the HIV-1-induced degradation of TRIMCyp is correlated with the specificity of restriction. HIV-1 containing the G89V mutation in the CypA binding loop of CA is incapable of binding CypA and is also not restricted by TRIMCyp. However, this viral mutant is susceptible to TRIM5alpharh restriction. Parallel cultures of 293T cells expressing either TRIMCyp or TRIM5alpharh were treated with cycloheximide and then challenged with equivalent quantities of VSV-G pseudotyped HIV-GFP particles or the G89V CA mutant virus. As seen in Figure 3C, exposure to wild type HIV-1 induced accelerated loss of both TRIMCyp and TRIM5alpharh. By contrast, exposure to the G89V mutant particles resulted in loss of TRIM5alpharh but not TRIMCyp. These results indicate that exposure of cells to HIV-1 results in destabilization of TRIMCyp by a mechanism requiring recognition of the incoming HIV-1 core by the restriction factor.
###end p 26
###begin title 27
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 60 63 <span type="species:ncbi:11786">MLV</span>
Human TRIM5alpha is Destabilized Upon Encounter of N-tropic MLV
###end title 27
###begin p 28
###xml 10 12 6 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 222 224 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 407 416 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s002">Figure S2</xref>
###xml 430 437 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s006">Text S1</xref>
###xml 518 520 498 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 538 541 518 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 561 570 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g004">Figure 4A</xref>
###xml 645 647 609 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 655 664 619 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g004">Figure 4A</xref>
###xml 771 773 731 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 776 779 736 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 786 802 746 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g004">Figure 4A and 4B</xref>
###xml 932 941 888 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g004">Figure 4B</xref>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 47 50 <span type="species:ncbi:11786">MLV</span>
###xml 76 79 <span type="species:ncbi:11786">MLV</span>
###xml 246 249 <span type="species:ncbi:11786">MLV</span>
###xml 346 349 <span type="species:ncbi:11786">MLV</span>
###xml 590 593 <span type="species:ncbi:11786">MLV</span>
###xml 730 733 <span type="species:ncbi:11786">MLV</span>
TRIM5alphahu cannot restrict HIV-1 or B-tropic MLV but potently restricts N-MLV. To further test the link between TRIM5alpha destabilization and retrovirus restriction, we challenged 293T cells stably expressing TRIM5alphahu with N- and B-tropic MLV viruses and measured TRIM5alpha levels following infection. The GFP-transducing N- and B-tropic MLV stocks were first titrated on nonrestrictive CrFK cells (Figure S2, detailed in Text S1) then normalized to ensure equivalent dosing. Mock-treated cells lost TRIM5alphahu at a slow rate (t1/2approximately2.5 h; Figure 4A). Challenge with B-MLV did not significantly affect the rate of TRIM5alphahu decay (Figure 4A). By contrast, cells challenged with an equivalent quantity of N-MLV showed accelerated loss of TRIM5alphahu (t1/2<1 h) (Figure 4A and 4B). The relative band intensities of the TRIM5alpha levels for this experiment were calculated and are represented in the graph in Figure 4B. These results, together with the TRIM5alpha and TRIMCyp data, establish a strong correlation between virus-induced TRIM5alpha destabilization and the specificity of restriction.
###end p 28
###begin title 29
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 88 91 <span type="species:ncbi:11786">MLV</span>
Human TRIM5alpha is destabilized upon challenge of cells with N-tropic but not B-tropic MLV.
###end title 29
###begin p 30
###xml 46 48 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 244 253 240 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s003">Figure S3</xref>
###xml 151 154 <span type="species:ncbi:11786">MLV</span>
(A) 293T cells expressing HA-tagged TRIM5alphahu were pretreated for 1 hr with cycloheximide and exposed to stocks of VSV-G-pseudotyped N- or B-tropic MLV or media alone (Mock). Integrated intensity values for the individual bands are shown in Figure S3. (B) Quantitation of TRIM5alpha levels utilizing Odyssey Band imaging software. Data shown are from one representative of three independent experiments.
###end p 30
###begin title 31
Virus-induced TRIM5alpha Destabilization is Correlated with Lentiviral Restriction in Old and New World Monkeys
###end title 31
###begin p 32
###xml 153 156 141 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 171 174 159 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 232 234 212 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
###xml 394 397 366 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 412 414 380 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
###xml 513 519 481 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac239</sub>
###xml 764 766 728 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 840 843 804 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 855 864 819 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g005">Figure 5A</xref>
###xml 910 913 870 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 954 957 914 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac</sub>
###xml 969 978 929 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g005">Figure 5A</xref>
###xml 991 993 947 949 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
###xml 1082 1097 1038 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g005">Figure 5A and B</xref>
###xml 116 123 <span type="species:ncbi:9491">tamarin</span>
###xml 183 188 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 196 209 <span type="species:ncbi:9511">spider monkey</span>
###xml 500 505 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 818 823 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 884 887 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
TRIM5alpha proteins from different primates differ in their ability to restrict specific lentiviruses. For example, tamarin monkey TRIM5alpha (TRIM5alphatam) restricts SIVmac but not HIV-1, while spider monkey TRIM5alpha (TRIM5alphasp) restricts both viruses. To further test the correlation between virus-induced loss of TRIM5alpha and antiviral specificity, we stably expressed the TRIM5alphatam and TRIM5alphasp proteins in 293T cells and challenged them with equivalent titers of VSV-pseudotyped HIV-1 and SIVmac239 GFP reporter viruses (as determined by titration on permissive CrFK cells). The cell lines were found to restrict the respective viruses by at least ten-fold (data not shown). Immunoblot analysis of post-nuclear lysates revealed that TRIM5alpharh was specifically destabilized when challenged with HIV-1 but not upon SIVmac challenge (Figure 5A). By contrast, the SIV-restrictive TRIM5alphatam was destabilized only in response to SIVmac challenge (Figure 5A). TRIM5alphasp, which restricts both viruses, was degraded in response to challenge with either virus (Figure 5A and B). These results further strengthen the correlation between the specificity of retrovirus restriction and virus-induced destabilization of TRIM5alpha.
###end p 32
###begin title 33
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Destabilization of primate TRIM5alpha proteins is correlated with restriction of HIV-1 and SIVmac239.
###end title 33
###begin p 34
###xml 46 48 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 60 63 52 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 92 94 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
###xml 65 72 <span type="species:ncbi:9491">tamarin</span>
###xml 96 109 <span type="species:ncbi:9511">spider monkey</span>
###xml 206 209 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 215 218 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
(A) 293T cells expressing HA-tagged TRIM5alpharh, TRIM5alphatam (tamarin monkey), TRIM5alphasp (spider monkey), and were pretreated for 1 hour with cycloheximide then exposed to stocks of VSV-G pseudotyped HIV-GFP, SIV-GFP, or media alone (Mock). (B). Quantitation of relative TRIM5alpha levels. Data shown are from one representative of three independent experiments.
###end p 34
###begin title 35
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-Induced Destabilization of TRIM5alpha Requires Proteasome Activity
###end title 35
###begin p 36
###xml 365 367 353 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 428 432 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero1">[55]</xref>
###xml 540 548 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g001">Figure 1</xref>
###xml 629 631 609 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 633 648 613 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g006">Figure 6A and B</xref>
###xml 790 792 766 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 932 934 904 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1035 1037 1003 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 322 327 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 586 591 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 751 756 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 837 842 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 908 913 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A major mechanism for cellular protein degradation is via the 26S proteasome. Previous studies have shown that the turnover of TRIM5alpha is dependent on cellular proteasome activity. Furthermore, inhibition of proteasome activity overcomes the early block to reverse transcription imposed by TRIM5alpha. We asked whether HIV-1-induced destabilization of TRIM5alpharh is dependent on proteasome activity. As previously reported [55], treatment of cells with the proteasome inhibitor MG132 resulted in an accumulation of TRIM5alpha protein (Figure 1, 0 H.p.i.). MG132 also prevented the HIV-1-induced destabilization of TRIM5alpharh (Figure 6A and B). Additional studies revealed that epoxomicin, a more specific proteasome inhibitor, also blocked the HIV-1-induced degradation of TRIM5alpharh (data not shown). By contrast, infection by HIV-1 in the presence of the S-cathepsin inhibitor E64 did not prevent HIV-1-induced TRIM5alpharh degradation (data not shown), suggesting that endosomal proteases are not responsible for TRIM5alpharh destabilization. We conclude that the virus-induced degradation of TRIM5alpha is dependent on cellular proteasome activity.
###end p 36
###begin title 37
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-induced destabilization of TRIM5alpha is blocked by the proteasome inhibitor MG132.
###end title 37
###begin p 38
###xml 52 54 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 471 472 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 140 145 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 613 616 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 666 669 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A and B) 293T cells expressing HA-tagged TRIM5alpharh were cultured for 1 hour with cycloheximide and DMSO (Mock) or MG132 then exposed to HIV-1(VSV) with DMSO or MG132 (open or filled circles, respectively) or D10 media containing DMSO or MG132 (open or filled diamonds, respectively). Panel B shows quantitation of TRIM5alpha levels utilizing Odyssey imaging software. Data in this figure are from one of two independent experiments. (C). 293T cells expressing myc-His6-tagged TRIMCyp were cultured for 1 hour with cycloheximide and DMSO or MG132. The cells were then exposed for 5 hours to; VSV-G-pseudotyped HIV-GFP with either DMSO or MG132, VSV-G-pseudotyped HIV-GFP with the G89V capsid mutation (G89V) with either DMSO or MG132, or media alone containing DMSO or MG132 (Mock). (B) Quantitation of TRIMCyp levels utilizing Odyssey imaging software. Data in this figure are expressed as the average of the duplicate determinations, with the error bars depicting the range of values.
###end p 38
###begin p 39
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g006">Figure 6C</xref>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 161 164 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 185 188 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 278 283 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine whether HIV-1-induced destabilization of TRIMCyp depends on proteasome activity, we challenged TRIMCyp-expressing 293T cells with either restricted HIV-GFP or unrestricted HIV.G89V-GFP in the presence or absence of MG132. As shown in Figure 6C, MG132 prevented the HIV-1-induced loss of TRIMCyp. Infection with the unrestricted G89V virus did not alter TRIMCyp stability, while addition of MG132 stabilized the restriction factor.
###end p 39
###begin title 40
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-Induced Destabilization of Endogenous TRIM5alpha in Primate Cells
###end title 40
###begin p 41
###xml 582 584 570 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 769 778 757 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s004">Figure S4</xref>
###xml 1101 1103 1077 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1152 1154 1124 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1265 1267 1229 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1267 1268 1231 1232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 1403 1418 1367 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g007">Figure 7A and B</xref>
###xml 1448 1450 1408 1410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1450 1451 1410 1411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 1617 1619 1573 1575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1619 1620 1575 1576 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 2033 2035 1985 1987 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 2175 2184 2123 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g007">Figure 7B</xref>
###xml 496 510 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 922 936 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1699 1704 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1723 1728 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1903 1906 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
All of the previous experiments studying TRIM5alpha stability were conducted in transduced 293T cell lines in which TRIM5alpha was detected by virtue of a hemagglutinin epitope tag. In this setting, it was necessary to treat the cells with cycloheximide to detect virus-induced degradation of the restriction factor, potentially leading to artifacts due to general inhibition of protein synthesis. Virus titration experiments demonstrated markedly greater restriction in the transduced cells vs. rhesus macaque FRhK-4 cell line, indicating that the 293T cells overexpress TRIM5alpharh (our unpublished observations). Furthermore, while cycloheximide treatment had only a minor effect on restriction in FRhK-4 cells, the drug markedly reduced restriction in 293T cells (Figure S4). To probe the physiological relevance of our observations made in 293T cells, we sought a means of detecting endogenous TRIM5alpha protein in rhesus macaque cells. Using a monoclonal antibody against native TRIM5alpha for immunoblotting, we detected a band that was consistent in terms of molecular weight with TRIM5alpharh that was also absent in cells lacking TRIM5alpharh (data not shown). To confirm that the band is TRIM5alpha, we transfected FRhK-4 cells with either a TRIM5alpharh-specific siRNA duplex or a non-targeting control siRNA duplex and quantified the intensity of this band by immunoblotting. As shown in Figure 7A and B, transfection with TRIM5alpharh-specific siRNA resulted in a 72% decrease in intensity of the relevant band vs. FRhK-4 cells treated with the non-targeting control. Cells treated with the TRIM5alpharh-specific also exhibited a tenfold increase in permissiveness to infection with HIV-1 (data not shown). HIV-1 infection of FRhK-4 cells was not altered by treatment with the non-targeting siRNA control. As expected, treatment with either siRNA duplex did not affect permissiveness to SIV infection (data not shown). These results indicated that the monoclonal antibody is capable of detecting endogenous TRIM5alpharh in FRhK-4 cells. They further demonstrated that the transduced 293T cells express a 3.3 fold higher level of TRIM5alpha than FRhK-4 cells (Figure 7B).
###end p 41
###begin title 42
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 60 74 <span type="species:ncbi:9544">rhesus macaque</span>
HIV-1 specifically induces destabilization of TRIM5alpha in rhesus macaque cells.
###end title 42
###begin p 43
###xml 41 43 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 137 139 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 366 368 346 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 442 444 418 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 764 766 732 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 628 631 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Duplicate cultures of 293T-TRIM5alpharh and FRHK-4 cells were transfected on two consecutive days with siRNAs specific for TRIM5alpharh (TRIM5alpha) or a non-targeting control siRNA (NTC). 72 hours after the second transfection, proteins were extracted and analyzed by immunoblotting with a TRIM5alpha-specific monoclonal antibody. (B) Quantitation of TRIM5alpharh levels in siRNA-transfected cells by Odyssey imaging software. TRIM5alpharh levels following siRNA knockdown are expressed as the average of the duplicate determinations with the error bars depicting the range of values. (C) FRhK-4 cells were challenged with HIV-GFP(VSV) or media alone (Mock). Zero hour timepoint represents TRIM5alpha levels in uninfected cells. (D) Quantitation of TRIM5alpharh levels. Results shown are from one representative of three independent experiments.
###end p 43
###begin p 44
###xml 52 54 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 224 226 216 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 361 363 349 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 501 503 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 563 578 547 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g007">Figure 7C and D</xref>
###xml 656 658 636 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 84 98 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 374 379 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 596 601 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 676 <span type="species:ncbi:9544">rhesus macaque</span>
We next sought to determine if endogenous TRIM5alpharh was destabilized by HIV-1 in rhesus macaque cells. FRhK-4 cultures were inoculated with HIV-1 in the presence or absence of cycloheximide and the stability of TRIM5alpharh in response to infection was analyzed by immunoblotting. Initial experiments showed no effect of cycloheximide treatment on TRIM5alpharh levels in HIV-1-exposed cells (data not shown); therefore the drug was removed in all subsequent experiments. We observed that TRIM5alpharh levels were stable in FRhK-4 cells over the 4 hour period (Figure 7C and D). Infection with HIV-1 resulted in accelerated decay of endogenous TRIM5alpharh in rhesus macaque cells without any requirement of inhibition of protein synthesis.
###end p 44
###begin p 45
###xml 53 55 49 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 288 303 284 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g008">Figure 8A and B</xref>
###xml 365 367 357 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 437 439 425 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 547 549 531 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 633 635 613 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 236 241 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 320 325 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 389 392 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 504 509 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next sought to determine if the loss of TRIM5alpharh was specifically due to restriction or was a non-specific effect resulting from viral infection. In the absence of cycloheximide we infected FRhK-4 cells with equivalent titers of HIV-1 or SIVmac239 GFP reporter viruses. As seen in Figure 8A and B, infection with HIV-1 resulted in a potent loss of TRIM5alpharh while infection with SIV resulted in only a slight loss of TRIM5alpharh as compared to the control cells. We conclude that infection by HIV-1 results in a rapid loss of TRIM5alpharh in target cells and that this loss is directly related to the ability of TRIM5alpharh to restrict infection by the incoming virus.
###end p 45
###begin title 46
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-induced turnover of TRIM5alpha in primate cells specific to restriction and is blocked by the proteasome inhibitor MG132.
###end title 46
###begin p 47
###xml 188 190 184 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 312 314 304 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 608 610 596 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 98 101 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 107 110 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 495 498 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Duplicate cultures of FRhK-4 cells were exposed to stocks of VSV-G-pseudotyped HIV-GFP (HIV), SIV-GFP (SIV), or media alone (Mock) for a period of 4 hours then harvested and TRIM5alpharh levels quantified by immunoblotting. The zero hour sample corresponds to uninfected cells. (B) Quantitation of TRIM5alpharh levels in (A) utilizing Odyssey imaging software. (C) Duplicate cultures of FRhK-4 cells were treated for 1 hour with DMSO or MG132, then exposed for 4 hours to: VSV-G-pseudotyped HIV-GFP with either DMSO or MG132, or media alone containing DMSO or MG132 (Mock). (D) Quantitation of TRIM5alpharh levels utilizing Odyssey imaging software. Data in this figure are expressed as the averages of the two determinations, with the error bars spanning the range of values.
###end p 47
###begin title 48
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-Induced Destabilization of Endogenous TRIM5alpha Requires Active Proteasomes
###end title 48
###begin p 49
###xml 84 86 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 249 251 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 303 318 295 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g008">Figure 8C and D</xref>
###xml 347 349 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 669 671 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 100 114 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 151 156 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 626 631 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 675 689 <span type="species:ncbi:9544">rhesus macaque</span>
We sought to determine if inhibition of proteasome function would restore TRIM5alpharh stability in rhesus macaque cells. FRhK-4 cells were exposed to HIV-1 in the presence or absence of MG132 for a period of four hours, and the levels of TRIM5alpharh were measured by immunoblotting. As can be seen in Figure 8C and D, MG132 stabilized TRIM5alpharh in HIV-1-exposed cells. Flow cytometry analysis of GFP signal in a small subset of the infected cells showed no difference in infection levels resulting from inhibition of proteasome function, which is consistent with previously published results. These results indicate that HIV-1-induced destabilization of TRIM5alpharh in rhesus macaque cells requires proteasome activity. They further suggest that the results we observed with TRIM5alpha-transduced 293T cells are unlikely to be an artifact of cycloheximide treatment.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 222 230 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 348 352 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Shi1">[60]</xref>
###xml 353 357 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Forshey1">[61]</xref>
###xml 671 679 651 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 679 683 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Xu1">[56]</xref>
###xml 791 795 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero1">[44]</xref>
###xml 796 800 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Javanbakht2">[49]</xref>
###xml 928 932 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero1">[55]</xref>
###xml 1041 1045 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Wu1">[58]</xref>
###xml 1046 1050 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Anderson1">[59]</xref>
###xml 1319 1321 1279 1281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1640 1642 1592 1594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1661 1663 1609 1611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 1685 1687 1629 1631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 2046 2049 1990 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Sayah1">[4]</xref>
###xml 2050 2053 1994 1997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Nisole1">[5]</xref>
###xml 2054 2058 1998 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Towers1">[38]</xref>
###xml 2316 2318 2252 2254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 2421 2423 2353 2355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 2725 2727 2653 2655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 202 207 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1279 1284 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1357 1362 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1583 1588 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1758 1761 <span type="species:ncbi:11786">MLV</span>
###xml 1798 1801 <span type="species:ncbi:11786">MLV</span>
###xml 1853 1858 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1968 1973 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2257 2260 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2264 2267 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 2273 2278 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2427 2432 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2599 2604 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2766 2771 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2779 2793 <span type="species:ncbi:9544">rhesus macaque</span>
While it is well established that TRIM5alpha limits the host range of many retroviruses, the precise mechanism of restriction remains undefined. TRIM5alpha can specifically associate with assemblies of HIV-1 CA-NC protein in vitro, and genetic evidence indicates that TRIM5alpha and TRIMCyp require an intact or semiintact viral capsid for binding [60],[61]. However, the detailed molecular consequences of the binding interaction to the viral core remain poorly defined. Two lines of evidence have implicated the ubiquitin-proteasome system in restriction. First, the delta isoform of TRIM5, which has a RING domain identical to that of TRIM5alpha, exhibits E3 activity in vitro[56]. Deletion or mutation of the RING domain in TRIM5alpha results in significant loss of restriction efficacy [44],[49]. TRIM5alpha is ubiquitinated in cells, although a role of this modification in retrovirus restriction has not been established [55]. Second, inhibition of proteasome activity alters the stage at which TRIM5alpha-mediated restriction occurs [58],[59]. The latter observation led us to hypothesize that the proteasome may participate in restriction by degrading a complex of TRIM5alpha with one or more incoming viral proteins. To test this, we asked whether exposure of cells to HIV-1 alters the stability of TRIM5alpharh. We observed that inoculation with HIV-1 results in an accelerated turnover of the restriction factor. Similar effects were observed in both 293T and HeLa cells (data not shown), suggesting that TRIM5alpha destabilization is not specific to a unique cell type. HIV-1 challenge resulted in destabilization of TRIM5alpharh but not TRIM5alphahu. Likewise, TRIM5alphahu was destabilized by inoculation of cells with restriction-sensitive N-MLV particles but not by unrestricted B-MLV. Similar results were seen in cells expressing the HIV-1-specific restriction factor TRIMCyp. Treatment of target cells with CsA, which blocks TRIMCyp restriction of HIV-1, or infection with virus containing mutations that prevent CypA binding [4],[5],[38], did not affect TRIMCyp stability. Specific loss of TRIM5alpha from cells expressing different primate alleles of the protein also correlated very well with the ability of those alleles to restrict HIV or SIV. The HIV-1-induced destabilization of TRIM5alpharh and TRIMCyp was prevented by inhibition of cellular proteasome activity. Destabilization of TRIM5alpharh by HIV-1 was also observed in a primate derived cell line without the need of cycloheximide to inhibit protein synthesis. This destabilization was specific for the restricted HIV-1 and was not observed in cells infected with an unrestricted virus. Inhibition of proteasome function restored TRIM5alpharh stability in response to infection by HIV-1 in the rhesus macaque cells. We conclude that TRIM5-related restriction factors are targeted for degradation by a proteasome-dependent mechanism following encounter of a restriction-sensitive retroviral core.
###end p 51
###begin p 52
###xml 281 285 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Campbell1">[62]</xref>
TRIM5alpha forms heterogenous structures in cells referred to as cytoplasmic bodies (CBs). While the role of CBs in restriction is unclear, TRIM5alpha protein in these structures rapidly exchanges with soluble TRIM5alpha, indicating that the protein is highly dynamic within cells [62]. We observed that most of the cellular TRIM5alpha can be degraded in response to exposure to a restriction-sensitive retrovirus, which implies that a majority of cellular TRIM5alpha molecules can engage incoming viral cores. If the CB-associated TRIM5alpha is inaccessible to incoming virus, our observation that a restricted virus can induce degradation of the majority of the TRIM5alpha molecules suggests that this protein rapidly redistributes to a compartment accessible to incoming virus.
###end p 52
###begin p 53
###xml 169 173 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero1">[55]</xref>
###xml 174 178 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero2">[63]</xref>
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-PerezCaballero2">[57]</xref>
###xml 250 259 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s005">Figure S5</xref>
TRIM5alpha and TRIMCyp are subject to proteasome-dependent turnover under steady-state conditions, yet its rapid turnover is not a prerequisite for restriction activity [55],[63]. Accordingly, proteasome inhibitors do not overcome restriction ([57]; Figure S5). Nonetheless, the effect of virus exposure on TRIM5alpha stability had heretofore not been reported. While alterations of specific individual portions of TRIM5alpha may alter its intrinsic stability, our results indicate that TRIM5alpha encounter with a restricted core results in degradation of the restriction factor by a proteasome-dependent mechanism.
###end p 53
###begin p 54
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Forshey2">[64]</xref>
###xml 657 661 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau3">[65]</xref>
###xml 662 666 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Perron2">[66]</xref>
###xml 997 1001 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau3">[65]</xref>
###xml 1002 1006 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Perron2">[66]</xref>
###xml 1282 1286 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-DiazGriffero3">[67]</xref>
###xml 197 202 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Retrovirus uncoating is a poorly characterized process, but can be defined as the disassembly of the viral capsid following penetration of the viral core into the target cell cytoplasm. Studies of HIV-1 CA mutants indicate that the stability of the viral capsid is properly balanced for productive uncoating in target cells: mutants with unstable capsids are impaired for viral DNA synthesis, suggesting that premature uncoating is detrimental to reverse transcription [64]. Thus a plausible mechanism for restriction is that binding of TRIM5alpha to the viral capsid inhibits infection directly by physically triggering premature uncoating in target cells [65],[66]. In this model, TRIM5alpha, perhaps with one or more cofactors, promotes the physical decapsidation of the virus core independently of proteolysis. Consistent with this view are studies demonstrating that TRIM5alpha restriction is associated with decreased recovery of sedimentable CA protein in lysates of acutely-infected cells [65],[66]. However, these studies fell short of demonstrating that the sedimentable CA protein was associated with intact viral cores. Furthermore, a recent study reported that treatment of cells with proteasome inhibitors prevented TRIM5alpha-dependent loss of particulate CA protein [67], indicating the potential involvement of proteasome activity in TRIM5alpha-induced virus uncoating.
###end p 54
###begin p 55
###xml 284 288 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Wu1">[58]</xref>
###xml 289 293 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Anderson1">[59]</xref>
###xml 622 626 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Chatterji1">[68]</xref>
###xml 880 884 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Galla1">[69]</xref>
###xml 1480 1484 1440 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Campbell2">[70]</xref>
###xml 1622 1626 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Shi1">[60]</xref>
###xml 142 147 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 613 618 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 659 662 <span type="species:ncbi:11786">MLV</span>
###xml 984 989 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Other studies further implicate the activity of the proteasome in TRIM5alpha-dependent restriction. Inhibition of proteasome activity rescues HIV-1 reverse transcription in TRIM5alpha-expressing cells, revealing a downstream block to nuclear import mediated by the restriction factor [58],[59]. Engagement of the viral capsid by TRIM5alpha may lead to proteasomal degradation of a TRIM5alpha-CA complex, resulting in functional decapsidation of the viral core and a premature uncoating phenotype. Consistent with this model, TRIM5alpha restriction has been associated with decreased intracellular accumulation of HIV-1 CA [68]. In addition, a recent study of MLV particle-mediated RNA cellular transfer reported reduced accumulation of viral CA protein in cells in a manner that was correlated with restriction by TRIM5alpha, and this effect was reversed by proteasome inhibition [69]. Unfortunately, our own efforts to detect an effect of TRIM5alpha on the stability of the incoming HIV-1 CA have thus far yielded negative results; thus we are reluctant to conclude at this stage that a specific component of the viral core is degraded as a complex with TRIM5alpha. Another potential mechanism is that proteasomal engagement of TRIM5alpha bound to the virus core results in physical dissociation of CA from the core followed by its release from TRIM5alpha, thus leading to destruction of the restriction factor and decapsidation of the core but not necessarily degradation of CA [70]. Genetic evidence from abrogation-of-restriction studies indicates that TRIM5alpha binding requires an intact or semiintact viral capsid [60], suggesting that TRIM5alpha binding to CA is highly dependent on avidity resulting from multivalent interactions with the polymeric viral capsid. It is thus plausible that CA is released from TRIM5alpha following forced uncoating. This model is attractive in its ability to reconcile most, if not all, of the reported data regarding the mechanism of restriction by TRIM5alpha.
###end p 55
###begin p 56
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 398 400 394 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 810 819 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s005">Figure S5</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 404 409 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 695 700 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 775 778 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
HIV-1 infection in many primate cell lines exhibits biphasic titration curves, and restriction can be abrogated in trans by high concentrations of VLPs, indicating that virus restriction is saturable. While it is generally assumed that the saturation occurs via sequestration of the restriction factor by the incoming virus, our results reveal another potential mechanism. Degradation of TRIM5alpharh by HIV-1 was tightly correlated with cellular susceptibility to infection by incoming virus, suggesting that loss of restriction at high virus input may occur via degradation of the restriction factor itself. Consistent with this view, treatment with MG132 resulted in a three-fold decrease in HIV-1 infection of FRhK-4 as well as OMK cells, while infection by unrestricted SIV was inhibited only marginally (Figure S5). This result, coupled with our observations of proteasome-dependent degradation of TRIM5alpha proteins in restrictive cells, suggests that depletion of TRIM5alpha via the proteasome contributes to the saturability of restriction.
###end p 56
###begin p 57
###xml 169 177 161 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 224 232 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 681 685 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Hoyt1">[71]</xref>
###xml 871 875 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Fang1">[72]</xref>
###xml 993 997 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Ohta1">[73]</xref>
###xml 998 1002 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Boutell1">[75]</xref>
###xml 410 415 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1058 1063 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The potential involvement of ubiquitylation in virus-induced degradation of TRIM5alpha degradation warrants further study. The autoubiquitylation of TRIM5delta observed in vitro suggests that TRIM5alpha may be ubiquitylated in trans upon polymerization of the restriction factor on a retroviral capsid. However, we have been unable to detect accumulation of cellular ubiquitylated TRIM5alpha species following HIV-1 inoculation either in the presence or absence of proteasome inhibitors (our unpublished observations). While many cellular proteins are regulated by ubiquitin-dependent proteolysis, ubiquitin-independent proteasomal degradation is also well documented (reviewed in [71]). Most E3 ligases are not degraded following ubiquitylation of a substrate, yet notable exceptions exist. The E3 enzyme Mdm2 is degraded following its ubiquitylation of its target, p53 [72], and the stability of several E3 ligases is related to their ubiquitylation status resulting from autoubiquitylation [73]-[75]. It will therefore be of interest to determine whether HIV-1-induced degradation of TRIM5alpha is dependent on host cell ubiquitylation and the TRIM5alpha RING domain.
###end p 57
###begin p 58
###xml 350 355 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The early post-entry stage of infection remains a fundamentally obscure part of the retrovirus life cycle. Our results provide novel evidence for a role for proteasome activity in TRIM5alpha restriction. Further mechanistic studies of TRIM5alpha may reveal novel approaches to antiviral therapy and fundamental insights into the molecular details of HIV-1 uncoating.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin title 60
Plasmids
###end title 60
###begin p 61
###xml 16 18 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 53 55 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 81 83 69 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
###xml 121 124 105 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 183 186 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 187 191 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Song1">[31]</xref>
###xml 245 249 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Bock1">[76]</xref>
###xml 336 339 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 381 385 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Aiken1">[77]</xref>
###xml 396 400 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-He1">[78]</xref>
###xml 411 415 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Cowan1">[23]</xref>
###xml 431 435 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Naviaux1">[79]</xref>
###xml 822 826 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Yee1">[80]</xref>
###xml 954 958 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Morgenstern1">[81]</xref>
###xml 1104 1106 1072 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 1127 1129 1091 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 1172 1178 1132 1138 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 1164 1206 1124 1166 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GATC<underline>GAATTC</underline>AGCTACTATGGCTTCTGGAATCCTG-3&#8242;</named-content>
###xml 1230 1236 1190 1196 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 1225 1258 1185 1218 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GT<underline>CTCGAG</underline>TCAAGCGTAGTCTGGGACG-3&#8242;</named-content>
###xml 1526 1532 1482 1488 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 1519 1554 1475 1510 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTAG<underline>CTCGAG</underline>TACAGAAGGAATGATCTGG-3&#8242;</named-content>
###xml 1824 1825 1780 1781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1932 1938 1884 1890 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 1927 1967 1879 1919 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GT<underline>CTCGAG</underline>AGAGCTTGGTGAGCACAGAGTCATGG-3&#8242;</named-content>
###xml 2130 2131 2082 2083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 2258 2264 2206 2212 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GTCGAC</underline>
###xml 2253 2293 2201 2241 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AC<underline>GTCGAC</underline>TTTCAATGGTGATGGTGATGATGACC-3&#8242;</named-content>
###xml 20 34 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 85 98 <span type="species:ncbi:9511">spider monkey</span>
###xml 126 133 <span type="species:ncbi:9491">tamarin</span>
###xml 560 565 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
###xml 1432 1442 <span type="species:ncbi:9505">owl monkey</span>
###xml 1608 1613 <span type="species:ncbi:9606">human</span>
pLPCX-TRIM5alpharh (rhesus macaque), pLPCX-TRIM5alphahu (human), pLPCX-TRIM5alphasp (spider monkey), and pLPCX-TRIM5alphatam (tamarin monkey) were generous gifts from Dr. J. Sodroski [3],[31]. pCIG-N and pCIG-B were generous gifts from J. Stoye [76]. pNL4-3 was obtained from the NIH AIDS Research and Reference Reagent Program and the env gene inactivated as previously described [77]. pHIV-GFP [78], pSIV-GFP [23], and pCL-ampho [79] were gifts from D. Gabuzda, P. Bieniasz, and B. Naviaux, respectively. R9-G89V was made by PCR mutagenesis of the wild type HIV-1 provirus R9 utilizing site-specific primers and verified by sequencing. pHIV-G89V-GFP was made by transfer of the BssHII-EcoRI fragment of R9-G89V into the BssHII-EcoRI sites of pHIV-GFP and verified by restriction digest. pHCMV-G was provided by J. Burns [80]. pBABE-eGFP was created by transfer of the BamHI-EcoRI fragment from peGFP (Clontech) into the BamHI-EcoRI sites of pBABE-puro [81]. pBABE-rhTRIM5alpha and pBABE-huTRIM5alpha were generated by PCR amplification of the rhesus and human TRIM5alpha sequences from pLPCX-TRIM5alpharh and pLPCX-TRIM5alphahu using primers TRIM5alpha-1(S)-Eco 5'- GATCGAATTCAGCTACTATGGCTTCTGGAATCCTG-3' and pTM1-TRIMHA-R 5'-GTCTCGAGTCAAGCGTAGTCTGGGACG-3' (EcoRI and XhoI sites underlined). The PCR products were digested and ligated into the EcoRI and SalI sites in pBABE-puro. A TRIMCyp cDNA was generated from oligo dT-primed owl monkey kidney cell cDNA and PCR amplified using the TRIM5alpha-1(S)-Eco and primer 5'-CTAGCTCGAGTACAGAAGGAATGATCTGG-3' (XhoI site underlined) specific to the 3'-UTR of the human cyclophilin A gene. This amplification results in a Arg to Gly substitution at codon 4 as compared to the original TRIMCyp cDNA. The product was ligated into the EcoRI-XhoI sites of plasmid CMX-PL1. The Myc-His6 tag was added to TRIMCyp by PCR amplification of CMX-PL1-TRIMCyp with TRIM5alpha-1(S)-Eco and primer 5'-GTCTCGAGAGAGCTTGGTGAGCACAGAGTCATGG-3' (XhoI site underlined). This product was then digested with EcoRI and XhoI and ligated into pcDNA 3.1/myc-His A (Invitrogen). The TRIMCyp containing the myc-(His)6 epitope tag was then amplified from TRIMCyp-pcDNA3.1/myc-His A using TRIM5alpha-1(S)-Eco and the primer pcDNA3.1 HIS-Sal 5'-ACGTCGACTTTCAATGGTGATGGTGATGATGACC-3', and the product digested with EcoRI and SalI and ligated into the corresponding sites in pBABE-puro. All constructs were verified via bidirectional DNA sequencing.
###end p 61
###begin title 62
Chemicals
###end title 62
###begin p 63
MG132 and cycloheximide were purchased from Sigma-Aldrich and used at final concentrations of 25 microM and 50 microM, respectively. Cyclosporin A was purchased from CalBiochem used at 2.5 microM final concentration. Epoxomicin was purchased from Boston Biochem and used at 10 microM. The cathepsin inhibitor E64 was purchased from Sigma-Aldrich and was used at 40 microM.
###end p 63
###begin title 64
Cells and Viruses
###end title 64
###begin p 65
###xml 218 223 218 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4.3</sub>
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 213 216 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 225 228 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 238 241 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 394 397 <span type="species:ncbi:11786">MLV</span>
###xml 1495 1500 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
FRhK-4 cells were purchased from the American Type Culture Collection. Cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1% penicillin/streptomycin. VSV-G-pseudotyped HIV-1NL4.3, HIV-GFP, and SIV-GFP viruses were produced by calcium phosphate transfection of 293T cells with proviral plasmid DNA (23 microg) and pHCMV-G (7 microg). N- and B-tropic MLV virus stocks were prepared by co-transfection of 23 microg pCIG-N or pCIG-B plasmids with pHCMV-G (7 microg) onto the cell line 293TeGFP. This cell line is a clone generated from 293T cells previously transduced with the retroviral vector pBABE-eGFP and isolated by limiting dilution and selected for high levels of GFP expression. Transfected cells were washed after 24 hours and replenished with fresh media. Supernatants were harvested 48-72 hours after transfection, clarified by passing through 0.45 microm filters, and stored in aliquots at -80degreesC. Retrovirus stocks for transduction of TRIM5alpha alleles were harvested from 293T cells transfected with the plasmids pCL-ampho (10 microg), the appropriate TRIM5alpha vector (15 microg), and pHCMV-G (5 microg). Viruses were collected 48 hours after transfection and used to transduce 293T cells. All 293T cell lines expressing TRIM5alpha proteins were polyclonal cell populations obtained by selection of transduced cells with puromycin. TRIMCyp-expressing cells were obtained by isolation of a single cell clone via limiting dilution. HIV-1 was strongly restricted in these cells, and restriction was prevented by the addition of 5 microg/ml cyclosporin A (CsA).
###end p 65
###begin title 66
Infection Protocol
###end title 66
###begin p 67
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1151 1152 1115 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Cells were seeded in 6-well plates at a density of 1 to 1.25x106 cells/well and incubated overnight. Prior to infection, cultures were treated for 1 hour in 50 microM cycloheximide to block protein synthesis. In experiments involving proteasome inhibitors, cells were incubated with both cycloheximide and the appropriate inhibitor for 1 hour prior to infection. Viral stocks containing cycloheximide, polybrene (5 microg/mL), CsA (2.5 microM), and proteasome inhibitors were prewarmed to 37degreesC prior to addition to cells. After culturing for 1 hr, media from zero hour timepoints was removed and 1 ml of PBS was added. Cells were then detached from the plate by flushing, pelleted, washed in PBS, repelleted, and the pellets frozen at -80degreesC. Cells that were challenged with virus had media removed and replaced with viral stock and were returned to 37degreesC. Individual cultures were harvested hourly using same procedure as previously described for the zero hour timepoints. All cell pellets were frozen at -80degreesC prior to analysis. For experiments utilizing FRhK-4 cells the cells were seeded in 6 well plates at a density of 3x105 cells/well and incubated overnight. Prewarmed viral stocks containing polybrene (5 microg/mL) were added the following day with a well harvested at the time of viral addition serving as the zero hour timepoint. Cells were incubated with the viral stock for the indicated time period then trypsinized, placed in fresh D10 media at a 1:1 volume, pelleted, washed in 1 mL complete D10 media to inactivate trypsin, repelleted, washed 2 times in 1 mL PBS, then frozen at -80degreesC. In experiments with FRhK-4 cells involving MG132, the cells were incubated with inhibitor for one hour prior to viral addition with the zero hour timepoint being an uninfected well harvested after 1 hour pretreatment.
###end p 67
###begin title 68
###xml 29 31 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
siRNA Knockdown of TRIM5alpharh
###end title 68
###begin p 69
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 139 141 135 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 157 160 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000074-Stremlau1">[3]</xref>
###xml 804 806 792 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 943 944 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1338 1341 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1346 1349 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
293T and FRhK-4 cells were seeded at a density of 2x105 cells per well in 6-well plates and incubated overnight. 24 hours later, TRIM5alpharh-specific siRNA [3], or a non-targeting control siRNA (Dharmacon), were diluted to a concentration of 3 microM in 1x siRNA buffer then transfected into cells using Dharmafect 1 transfection reagent and OptiMEM I (Gibco) according to manufacturers protocol (Dharmacon). Cells were then incubated overnight and retransfected with siRNAs again the following day utilizing the identical protocol. 48 hours after the first siRNA transfection the cells were removed from the 6-well plates and plated onto a 10 cm dish in complete D10 media at a ratio of 1 well to 1 10 cm dish and incubated for either 24 or 48 hours. 24 hours later, one 10 cm dish of either TRIM5alpharh-specific siRNA treated cells or non-targeting control treated cells were trypsinized and replated in 24 well plates at a density of 2x105 cells/well then incubated overnight. The following day the remaining two 10 cm dishes of siRNA treated cells were trypsinized, diluted 1:1 in D10 media, pelleted, washed 1x in D10 media to inactivate trypsin, repelleted, washed 2x in 1 mL PBS per wash, repelleted, then frozen at -80degreesC. Cells that had been seeded the prior day in the 24 well plates were then infected with dilutions of HIV and SIV-GFP, incubated for 48 hours, then analyzed for GFP expression by flow cytometry.
###end p 69
###begin title 70
Protein Analyses
###end title 70
###begin p 71
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 503 506 <span type="species:ncbi:10116">rat</span>
###xml 572 576 <span type="species:ncbi:9925">goat</span>
###xml 582 585 <span type="species:ncbi:10116">rat</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 753 757 <span type="species:ncbi:9925">goat</span>
###xml 763 768 <span type="species:ncbi:10090">mouse</span>
###xml 866 871 <span type="species:ncbi:10090">mouse</span>
###xml 943 947 <span type="species:ncbi:9925">goat</span>
###xml 953 958 <span type="species:ncbi:10090">mouse</span>
###xml 1036 1042 <span type="species:ncbi:9986">rabbit</span>
###xml 1102 1106 <span type="species:ncbi:9925">goat</span>
###xml 1112 1118 <span type="species:ncbi:9986">rabbit</span>
Cell pellets were thawed and lysed in a solution containing 100 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 0.5% NP-40. Nuclei were pelleted via centrifugation at 16,000xg for 10 minutes and post-nuclear supernatants were removed. Protein levels were quantified via BCA assay (Pierce). Samples, normalized for total protein, were denatured in SDS and subjected to electrophoresis on 4-20% acrylamide gradient gels (BioRad). Proteins were transferred to nitrocellulose and probed with HA-epitope tag-specific rat monoclonal antibody (3F10, Roche) and Alexa Fluor 680 conjugated goat anti-rat IgG (Molecular Probes). Cells expressing TRIMCyp were probed with the myc epitope-specific mouse monoclonal antibody (9E10, Invitrogen) and Alexa Fluor 680-conjugated goat anti-mouse IgG (Molecular Probes). Proteins extracted from FRhK-4 cells were probed the TRIM5alpha-specific mouse polyclonal antibody (IMG-5354, Imgenex) and Alexa Fluor 680 conjugated goat anti-mouse IgG (Molecular Probes). All immunoblots were probed with beta-actin-specific rabbit monoclonal antibody (A2228, Sigma) and IRDye800-conjugated goat anti-rabbit IgG (Rockland). Dilutions of antibodies were 1:1000 and 1:5000 for primary and secondary respectively with the exception of IMG-5354 which was used at a dilution of 1:2000. Bands were detected by scanning blots with the LI-COR Odyssey Imaging System using both 700 and 800 channels, and integrated intensities were determined using the LI-COR Odyssey band quantitation software with the median top-bottom background subtraction method. The TRIM5alpha band intensities were then normalized to the signals from the corresponding beta-actin bands. All signals were then expressed as a percentage of the initial TRIM5alpha/actin band intensity ratio.
###end p 71
###begin title 72
Genes used in this study
###end title 72
###begin p 73
###xml 10 12 6 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 35 37 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 80 83 68 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tam</sub>
###xml 106 108 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp</sub>
TRIM5alpharh (AY523632); TRIM5alphahu (AF220025); TRIMCyp (AY646198); TRIM5alphatam (AY740615); TRIM5alphasp (AY740616).
###end p 73
###begin title 74
Supporting Information
###end title 74
###begin p 75
###xml 56 65 56 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g002">Figure 2A</xref>
Integrated Intensity Values for Bands for immunoblot in Figure 2A.
###end p 75
###begin p 76
(0.20 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 60 62 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 35 38 <span type="species:ncbi:11786">MLV</span>
Titration Curve of N- and B-Tropic MLV viruses on TRIM5alphahu and CrFK cells.
###end p 78
###begin p 79
(0.05 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 56 65 56 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000074-g004">Figure 4A</xref>
Integrated Intensity Values for Bands for immunoblot in Figure 4A.
###end p 81
###begin p 82
(0.10 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 64 66 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rh</sub>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effects of cycloheximide on HIV-1 restriction in 293T-TRIM5alpharh and FRhK-4 cells.
###end p 84
###begin p 85
(0.29 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effects of MG132 on HIV-1 restriction in simian cell lines.
###end p 87
###begin p 88
(0.46 MB EPS)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 23 33 23 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s002">Figures S2</xref>
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s004">S4</xref>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000074.s005">S5</xref>
Supporting Methods for Figures S2, S4, and S5.
###end p 90
###begin p 91
(0.03 MB DOC)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
The authors thank Jiong Shi and Stephanie Buck for technical assistance, and P. Bieniasz, J. Sodroski, and J. Stoye for plasmids.
###end p 93
###begin title 94
References
###end title 94
###begin article-title 95
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Positional cloning of the mouse retrovirus restriction gene Fv1.
###end article-title 95
###begin article-title 96
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
###end article-title 96
###begin article-title 97
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
###end article-title 97
###begin article-title 98
###xml 53 63 <span type="species:ncbi:9505">owl monkey</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.
###end article-title 98
###begin article-title 99
###xml 46 56 <span type="species:ncbi:9505">owl monkey</span>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.
###end article-title 99
###begin article-title 100
Intrinsic immunity: a front-line defense against viral attack.
###end article-title 100
###begin article-title 101
Retrovirus restriction factors.
###end article-title 101
###begin article-title 102
Retroviral restriction by APOBEC proteins.
###end article-title 102
###begin article-title 103
APOBEC-mediated viral restriction: not simply editing?
###end article-title 103
###begin article-title 104
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin, TRIM5, and innate immunity to HIV-1.
###end article-title 104
###begin article-title 105
###xml 61 84 <span type="species:ncbi:11786">murine leukemia viruses</span>
A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures.
###end article-title 105
###begin article-title 106
###xml 61 84 <span type="species:ncbi:11786">murine leukemia viruses</span>
A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses.
###end article-title 106
###begin article-title 107
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Susceptibility to two strains of Friend leukemia virus in mice.
###end article-title 107
###begin article-title 108
###xml 36 57 <span type="species:ncbi:11786">murine leukemia virus</span>
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro.
###end article-title 108
###begin article-title 109
###xml 100 121 <span type="species:ncbi:11786">murine leukemia virus</span>
Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus.
###end article-title 109
###begin article-title 110
Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line.
###end article-title 110
###begin article-title 111
###xml 33 39 <span type="species:ncbi:10090">Murine</span>
Single Amino Acid Changes in the Murine Leukemia Virus Capsid Protein Gene Define the Target of Fv1Resistance.
###end article-title 111
###begin article-title 112
###xml 70 93 <span type="species:ncbi:11786">murine leukemia viruses</span>
Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses.
###end article-title 112
###begin article-title 113
###xml 133 154 <span type="species:ncbi:11786">murine leukemia virus</span>
Reversal of Fv-1 host range by in vitro restriction endonuclease fragment exchange between molecular clones of N-tropic and B-tropic murine leukemia virus genomes.
###end article-title 113
###begin article-title 114
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A dominant block to HIV-1 replication at reverse transcription in simian cells.
###end article-title 114
###begin article-title 115
Species-specific, postentry barriers to primate immunodeficiency virus infection.
###end article-title 115
###begin article-title 116
Restriction of multiple divergent retroviruses by Lv1 and Ref1.
###end article-title 116
###begin article-title 117
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 62 91 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.
###end article-title 117
###begin article-title 118
Restriction of lentivirus in monkeys.
###end article-title 118
###begin article-title 119
Lv2, a novel postentry restriction, is mediated by both capsid and envelope.
###end article-title 119
###begin article-title 120
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 39 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.
###end article-title 120
###begin article-title 121
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.
###end article-title 121
###begin article-title 122
###xml 28 63 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 68 104 <span type="species:ncbi:11711">simian immunodeficiency virus SIVmac</span>
Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
###end article-title 122
###begin article-title 123
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
###end article-title 123
###begin article-title 124
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 34 <span type="species:ncbi:9534">African green monkey</span>
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
###end article-title 124
###begin article-title 125
Retrovirus Restriction by TRIM5{alpha} Variants from Old World and New World Primates.
###end article-title 125
###begin article-title 126
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
###end article-title 126
###begin article-title 127
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 44 65 <span type="species:ncbi:11786">murine leukemia virus</span>
Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
###end article-title 127
###begin article-title 128
###xml 93 121 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
###end article-title 128
###begin article-title 129
###xml 15 44 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
###end article-title 129
###begin article-title 130
###xml 52 75 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
###end article-title 130
###begin article-title 131
###xml 28 33 <span type="species:ncbi:9606">human</span>
Antiretroviral potential of human tripartite motif-5 and related proteins.
###end article-title 131
###begin article-title 132
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
###end article-title 132
###begin article-title 133
###xml 41 58 <span type="species:ncbi:9545">Macaca nemestrina</span>
###xml 63 82 <span type="species:ncbi:9541">Macaca fascicularis</span>
TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis.
###end article-title 133
###begin article-title 134
###xml 48 66 <span type="species:ncbi:9545">pig-tailed macaque</span>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection.
###end article-title 134
###begin article-title 135
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.
###end article-title 135
###begin article-title 136
###xml 49 64 <span type="species:ncbi:9544">rhesus macaques</span>
Independent evolution of an antiviral TRIMCyp in rhesus macaques.
###end article-title 136
###begin article-title 137
The tripartite motif family identifies cell compartments.
###end article-title 137
###begin article-title 138
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
###end article-title 138
###begin article-title 139
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
###end article-title 139
###begin article-title 140
###xml 74 94 <span type="species:ncbi:9534">African green monkey</span>
###xml 149 185 <span type="species:ncbi:11711">simian immunodeficiency virus SIVmac</span>
A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
###end article-title 140
###begin article-title 141
Retroviral restriction factor TRIM5alpha is a trimer.
###end article-title 141
###begin article-title 142
###xml 69 97 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.
###end article-title 142
###begin article-title 143
The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
###end article-title 143
###begin article-title 144
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
###end article-title 144
###begin article-title 145
Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
###end article-title 145
###begin article-title 146
###xml 52 57 <span type="species:ncbi:9606">human</span>
Unique features of TRIM5alpha among closely related human TRIM family members.
###end article-title 146
###begin article-title 147
TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases.
###end article-title 147
###begin article-title 148
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases.
###end article-title 148
###begin article-title 149
Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.
###end article-title 149
###begin article-title 150
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta.
###end article-title 150
###begin article-title 151
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.
###end article-title 151
###begin article-title 152
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.
###end article-title 152
###begin article-title 153
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
###end article-title 153
###begin article-title 154
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Saturation of TRIM5[alpha]-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.
###end article-title 154
###begin article-title 155
###xml 47 52 <span type="species:ncbi:9606">Human</span>
Structural Requirements for Recognition of the Human Immunodeficiency Virus Type 1 Core during Host Restriction in Owl Monkey Cells.
###end article-title 155
###begin article-title 156
TRIM5{alpha} Cytoplasmic Bodies Are Highly Dynamic Structures.
###end article-title 156
###begin article-title 157
Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain.
###end article-title 157
###begin article-title 158
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.
###end article-title 158
###begin article-title 159
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
###end article-title 159
###begin article-title 160
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 87 108 <span type="species:ncbi:11786">murine leukemia virus</span>
The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
###end article-title 160
###begin article-title 161
Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
###end article-title 161
###begin article-title 162
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry.
###end article-title 162
###begin article-title 163
Cellular restriction of retrovirus particle-mediated mRNA transfer.
###end article-title 163
###begin article-title 164
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
###end article-title 164
###begin article-title 165
Ubiquitin-free routes into the proteasome.
###end article-title 165
###begin article-title 166
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53.
###end article-title 166
###begin article-title 167
Association with cullin partners protects ROC proteins from proteasome-dependent degradation.
###end article-title 167
###begin article-title 168
###xml 96 101 <span type="species:ncbi:9606">human</span>
Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
###end article-title 168
###begin article-title 169
###xml 30 57 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.
###end article-title 169
###begin article-title 170
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
###end article-title 170
###begin article-title 171
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 106 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 115 120 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
###end article-title 171
###begin article-title 172
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia.
###end article-title 172
###begin article-title 173
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.
###end article-title 173
###begin article-title 174
Generation of high-titer pseudotyped retroviral vectors with very broad host range.
###end article-title 174
###begin article-title 175
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
###end article-title 175
###begin p 176
The authors have declared that no competing interests exist.
###end p 176
###begin p 177
Supported by NIH grants AI050423 and AI76121. CJR was supported from NIH training grants T32GM008554 and T32AI060571.
###end p 177

